RT @blueyedgenes: @cdbustamante Thanks! My chapter 1 is published - https://t.co/OfuWfhAdRB and hoping to publish chapter 2 (survey of DTC…
@cdbustamante Thanks! My chapter 1 is published - https://t.co/OfuWfhAdRB and hoping to publish chapter 2 (survey of DTC customers) soon
In my study of third-party genetic apps, only 2 exclusively accessed user genotypes via @23andMeAPI: @infinome and @DNAFitHQ. What has this meant for those apps? Other offered API as one option; raw data file upload as another. https://t.co/FqYXMLk7O9
"Bridge to the Literature"? Third-Party Genetic Interpretation Tools and the Views of Tool Developers. https://t.co/ZTJXeMiYQz #pgen #pgsethics #medlibs #genetics
Delighted to have my article with @smfullerton highlighted as "required reading" by editor Christina Palmer in Aug. issue of @NSGC Journal of Genetic Counseling https://t.co/OfuWfhAdRB https://t.co/LGZx1gCGyQ
@BethSkw @antonioregalado @Singularitybook @razibkhan See also Table 1 here: https://t.co/FqYXML2wpz
@_StaceyPereira @promethease Fantastic, I look forward to reading that! Are you planning to ask parents whether they were motivated to request raw data b/c they wanted to use third-party interpretation tools? Few accept VCF (see https://t.co/FqYXML2wpz)
Third-party tools vary widely in how they source and report information to users. See my forthcoming Journal of Genetic Counseling (@GeneticCouns) article with comprehensive review of 23 tools, plus interviews with tool developers: https://t.co/FqYXML2wpz
Great overview of DTC genetics past, present, and future. Appreciate the mention of raw data and third party interpretation, an oft overlooked aspect. My recent review of third party tools here: https://t.co/FqYXML2wpz. Currently analyzing survey data @ co
RT @blueyedgenes: I’ve done a comprehensive review of 3rd party interpretation tools, including interviewing tool developers. https://t.co/86ElPGosi0 #GenCSM https://t.co/C03ksji9k6
RT @blueyedgenes: I've done a comprehensive review of 3rd party interpretation tools, including interviewing tool developers. https://t.co/…
RT @blueyedgenes: I've done a comprehensive review of 3rd party interpretation tools, including interviewing tool developers. https://t.co/…
RT @blueyedgenes: I've done a comprehensive review of 3rd party interpretation tools, including interviewing tool developers. https://t.co/…
I've done a comprehensive review of 3rd party interpretation tools, including interviewing tool developers. https://t.co/FqYXML2wpz #GenCSM https://t.co/PX3gmZ31dT
RT @mraganhart: Do third-party genetic analysis tools interpret data, or simply “bridge to the literature”? If you build it they will come.…
Do third-party genetic analysis tools interpret data, or simply “bridge to the literature”? If you build it they will come. Consumers craving more from their GDFs&VCFs. Should be required reading for those w/non-genetics background to provide context f
@antonioregalado @DrKhouryCDC @JAMA_current Agreed, regulation of interpretation-only tools otherwise unbundled from genotyping/sequencing seems to be regulatory gray area, including for tool developers I interviewed: https://t.co/FqYXML2wpz
Link to published article here: https://t.co/FqYXML2wpz
@gedankenstuecke Here is the Sharedit link: https://t.co/FqYXML2wpz. Pls let me know if it doesn’t work for you!
RT @PhilippBayer: A very nice overview of direct-to-consumer genetic testing tools for private users ('bridging tools') and what their deve…
Just out: Sarah C. Nelson & Stephanie M. Fullerton: “‘Bridge to the Literature’? Third-Party Genetic Interpretation Tools and the Views of Tool Developers” https://t.co/2i3J5q1KcZ (£)
RT @PhilippBayer: A very nice overview of direct-to-consumer genetic testing tools for private users ('bridging tools') and what their deve…
A very nice overview of direct-to-consumer genetic testing tools for private users ('bridging tools') and what their developers think https://t.co/8WzblAL1zN With @gedankenstuecke quotes and @openSNPorg !